No, do not increase fluoxetine to 80 mg for bulimia nervosa
The standard and recommended dose of fluoxetine for bulimia nervosa is 60 mg daily, and there is no evidence supporting routine escalation to 80 mg. 1, 2
Evidence-Based Dosing for Bulimia Nervosa
The 2023 APA guidelines explicitly recommend 60 mg fluoxetine daily as the standard pharmacological treatment for adults with bulimia nervosa 1. This recommendation is based on controlled clinical trials where only the 60 mg dose—not 20 mg—was statistically superior to placebo in reducing binge-eating and vomiting frequency 2.
The FDA label is unequivocal on this point: "Fluoxetine doses above 60 mg/day have not been systematically studied in patients with bulimia" 2. While the label notes that doses up to 80 mg/day have been "well tolerated in open studies of OCD" with a maximum dose not exceeding 80 mg/day 2, this applies specifically to obsessive-compulsive disorder, not bulimia nervosa.
Clinical Decision Algorithm
If the patient is not responding adequately to 60 mg fluoxetine:
- First priority: Ensure the patient is receiving eating disorder-focused cognitive-behavioral therapy (CBT), as the APA recommends this as the primary treatment with fluoxetine as an adjunct 1
- Second: Verify medication adherence and adequate trial duration (at least 6-8 weeks at 60 mg)
- Third: Assess for severe purging behavior and obtain an ECG, as fluoxetine can prolong QTc intervals 1
- Fourth: Consider switching to a different antidepressant rather than exceeding 60 mg fluoxetine, given the lack of systematic evidence for higher doses in bulimia
Important Caveats
The research literature does contain older studies using 80 mg fluoxetine for bulimia 3, 4, 5, but these were small, open-label trials from the late 1980s and early 1990s. The controlled trials that established fluoxetine's FDA approval used 60 mg as the effective dose 2. More recent comprehensive reviews consistently identify 60 mg as the standard dose 6, 7, 8, 9.
Common pitfall: Clinicians may be tempted to increase the dose when response is inadequate, but the evidence suggests that inadequate response at 60 mg more likely reflects the need for intensified psychotherapy or consideration of alternative medications rather than dose escalation beyond studied ranges.
The patient should remain on 60 mg daily while optimizing the psychotherapeutic component of treatment, which is the cornerstone of bulimia nervosa management 1.